Beyond Cancer Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
| XAIR Stock | USD 0.46 0.01 1.91% |
Slightly above 53% of Beyond Air's investor base is interested to short. The analysis of overall sentiment of trading Beyond Air stock suggests that many investors are impartial at this time. Beyond Air's investing sentiment overview a quick insight into current market opportunities from investing in Beyond Air. Many technical investors use Beyond Air stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Beyond |
50,000 or 100,000 ppm UNO alone or in combination with anti-mCTLA-4 more than tripled antigen specific central memory T-cell response versus anti-mCTLA-4 alone Pooled analysis of combination studies of 50,000 or 100,000 ppm UNO with anti-mPD-1 demonstrated more than a doubling in survival at Day 75 versus anti-mPD-1 alone Initial data from a Phase 1a, first-in-human study to be presented at the Society for Immunotherapy in Cancer on November 3, 2023 GARDEN CITY, N.Y. and HAMILTON, Bermuda
Read at finance.yahoo.com
 |
Beyond Air Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Beyond Air can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Beyond Air Fundamental Analysis
We analyze Beyond Air's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Air using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Air based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Beyond Air is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Beyond Air Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Beyond Air stock to make a market-neutral strategy. Peer analysis of Beyond Air could also be used in its relative valuation, which is a method of valuing Beyond Air by comparing valuation metrics with similar companies.
Peers
Beyond Air Related Equities
| DCTH | Delcath Systems | 9.00 | ||||
| CTKB | Cytek Biosciences | 3.38 | ||||
| CVRX | CVRx | 2.26 | ||||
| TMDX | TransMedics | 1.48 | ||||
| NPCE | Neuropace | 1.10 | ||||
| KIDS | Orthopediatrics Corp | 0.91 | ||||
| CLPT | Clearpoint Neuro | 0.00 | ||||
| LUNG | Pulmonx Corp | 0.00 | ||||
| ELMD | Electromed | 1.47 | ||||
| TMCI | Treace Medical | 1.70 | ||||
| LUCD | Lucid Diagnostics | 2.37 | ||||
| NARI | Inari Medical | 2.45 | ||||
| TELA | Tela Bio | 2.46 | ||||
| SGHT | Sight Sciences | 3.76 | ||||
| RCEL | Avita Medical | 4.68 |
Additional Tools for Beyond Stock Analysis
When running Beyond Air's price analysis, check to measure Beyond Air's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beyond Air is operating at the current time. Most of Beyond Air's value examination focuses on studying past and present price action to predict the probability of Beyond Air's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beyond Air's price. Additionally, you may evaluate how the addition of Beyond Air to your portfolios can decrease your overall portfolio volatility.